NCT06875323View on ClinicalTrials.gov

FostrSpace-CASA R61/R33

NAActive, not recruitingINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

March 1, 2024

Primary Completion Date

March 1, 2029

Study Completion Date

March 1, 2029

Conditions
Substance Use
Interventions
OTHER

ECHO-FostrSpace

Six ECHO-FostrSpace session training for CASA volunteers.

OTHER

Informational Session

One ECHO-FostrSpace session training for CASA volunteers.

Trial Locations (1)

94131

UCSF Zuckerberg San Francisco General Hospital, San Francisco

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

University of California, San Francisco

OTHER

NCT06875323 - FostrSpace-CASA R61/R33 | Biotech Hunter | Biotech Hunter